Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   hairy cell leukemia
  

Disease ID 528
Disease hairy cell leukemia
Definition
A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow.
Synonym
[m]hairy cell leukaemia
[m]hairy cell leukemia
[m]leukaemic reticuloendotheliosis
[m]leukaemic reticuloendotheliosis (disorder)
[m]leukemic reticuloendotheliosis
cell hairy leukemia
cells hairy leukemia
hairy cell leukaemia
hairy cell leukaemia (clinical)
hairy cell leukemia (clinical)
hairy cell leukemia (disorder)
hairy cell leukemia (morphologic abnormality)
hairy cell leukemias
hairy t cell leukemia
hairy-cell leukaemia
hairy-cell leukemia
hcl - hairy cell leukaemia
hcl - hairy cell leukemia
leukaemia hairy cell
leukaemic reticuloendotheliosis
leukaemic reticuloendotheliosis (clinical) [obs]
leukaemic reticuloendotheliosis -retired-
leukaemic reticuloendotheliosis nos
leukaemic reticuloendotheliosis of unspecified sites
leukemia hairy cell
leukemia, hairy cell
leukemia, hairy cell [disease/finding]
leukemias, hairy cell
leukemic reticuloendothelioses
leukemic reticuloendotheliosis
leukemic reticuloendotheliosis (clinical) [obs]
leukemic reticuloendotheliosis (morphologic abnormality)
leukemic reticuloendotheliosis -retired-
leukemic reticuloendotheliosis nos
leukemic reticuloendotheliosis nos (disorder)
leukemic reticuloendotheliosis of unspecified sites
leukemic reticuloendotheliosis of unspecified sites (disorder)
lre - leukaemic reticuloendotheliosis
lre - leukemic reticuloendotheliosis
reticuloendothelioses, leukemic
reticuloendotheliosis, leukemic
Orphanet
DOID
UMLS
C0023443
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:27)
C1261473  |  sarcoma  |  3
C0023418  |  leukemia  |  2
C0023448  |  lymphocytic leukemia  |  2
C0376545  |  hematologic malignancies  |  1
C0023473  |  chronic myeloid leukemia  |  1
C0349632  |  splenic marginal zone lymphoma  |  1
C0023470  |  myeloid leukemia  |  1
C0032285  |  pneumonia  |  1
C0036202  |  sarcoidosis  |  1
C0022658  |  nephropathy  |  1
C0021053  |  immune disorders  |  1
C0023448  |  lymphoblastic leukemia  |  1
C0023434  |  chronic lymphocytic leukemia  |  1
C0021053  |  immune disorder  |  1
C0015230  |  rash  |  1
C0025309  |  meningoencephalitis  |  1
C0006142  |  breast cancer  |  1
C1522378  |  large granular lymphocytic leukemia  |  1
C0004943  |  behcet's disease  |  1
C0019061  |  haemolytic uraemic syndrome  |  1
C0024299  |  lymphoma  |  1
C0042384  |  vasculitis  |  1
C0030312  |  pancytopenia  |  1
C0153687  |  skin metastasis  |  1
C0027947  |  neutropenia  |  1
C0018190  |  donovanosis  |  1
C0038034  |  sporotrichosis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:2)
673  |  BRAF  |  ORPHANET
5604  |  MAP2K1  |  CTD_human
Inferring Gene(Waiting for update.)
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:84)
55  |  ACPP  |  2.175  |  DISEASES
100  |  ADA  |  2.554  |  DISEASES
238  |  ALK  |  1.134  |  DISEASES
567  |  B2M  |  1.978  |  DISEASES
23066  |  CAND2  |  1.087  |  DISEASES
8573  |  CASK  |  1.109  |  DISEASES
930  |  CD19  |  4.727  |  DISEASES
914  |  CD2  |  2.973  |  DISEASES
4345  |  CD200  |  3.565  |  DISEASES
50489  |  CD207  |  1.401  |  DISEASES
951  |  CD37  |  2.478  |  DISEASES
958  |  CD40  |  2.309  |  DISEASES
959  |  CD40LG  |  3.308  |  DISEASES
960  |  CD44  |  1.502  |  DISEASES
921  |  CD5  |  5.046  |  DISEASES
1043  |  CD52  |  2.81  |  DISEASES
974  |  CD79B  |  2.265  |  DISEASES
978  |  CDA  |  4.747  |  DISEASES
1272  |  CNTN1  |  1.148  |  DISEASES
1380  |  CR2  |  2.912  |  DISEASES
1447  |  CSN2  |  1.433  |  DISEASES
79947  |  DHDDS  |  1.179  |  DISEASES
1758  |  DMP1  |  1.615  |  DISEASES
120526  |  DNAJC24  |  2.477  |  DISEASES
1791  |  DNTT  |  1.495  |  DISEASES
51611  |  DPH5  |  2.678  |  DISEASES
2045  |  EPHA7  |  1.084  |  DISEASES
30816  |  ERVW-1  |  1.963  |  DISEASES
2214  |  FCGR3A  |  1.557  |  DISEASES
115350  |  FCRL1  |  2.322  |  DISEASES
83416  |  FCRL5  |  3.626  |  DISEASES
84824  |  FCRLA  |  2.631  |  DISEASES
2335  |  FN1  |  2.366  |  DISEASES
2526  |  FUT4  |  2.21  |  DISEASES
53827  |  FXYD5  |  1.323  |  DISEASES
23464  |  GCAT  |  1.603  |  DISEASES
11245  |  GPR176  |  1.521  |  DISEASES
3161  |  HMMR  |  1.525  |  DISEASES
3384  |  ICAM2  |  1.622  |  DISEASES
3446  |  IFNA10  |  3.414  |  DISEASES
3451  |  IFNA17  |  2.56  |  DISEASES
3440  |  IFNA2  |  4.38  |  DISEASES
3456  |  IFNB1  |  2.252  |  DISEASES
100423062  |  IGLL5  |  1.538  |  DISEASES
112744  |  IL17F  |  1.537  |  DISEASES
3559  |  IL2RA  |  3.639  |  DISEASES
3561  |  IL2RG  |  1.641  |  DISEASES
3563  |  IL3RA  |  3.842  |  DISEASES
27152  |  INTU  |  1.963  |  DISEASES
79711  |  IPO4  |  3.964  |  DISEASES
10379  |  IRF9  |  1.071  |  DISEASES
3676  |  ITGA4  |  2.021  |  DISEASES
3683  |  ITGAL  |  2.424  |  DISEASES
3684  |  ITGAM  |  1.763  |  DISEASES
83700  |  JAM3  |  1.206  |  DISEASES
11127  |  KIF3A  |  1.145  |  DISEASES
3903  |  LAIR1  |  2.369  |  DISEASES
3909  |  LAMA3  |  1.528  |  DISEASES
4049  |  LTA  |  1.64  |  DISEASES
5609  |  MAP2K7  |  2.665  |  DISEASES
4311  |  MME  |  4.082  |  DISEASES
4332  |  MNDA  |  1.444  |  DISEASES
10232  |  MSLN  |  1.495  |  DISEASES
4609  |  MYC  |  1.713  |  DISEASES
4615  |  MYD88  |  2.075  |  DISEASES
79400  |  NOX5  |  1.144  |  DISEASES
26471  |  NUPR1  |  1.054  |  DISEASES
4942  |  OAT  |  1.21  |  DISEASES
64065  |  PERP  |  1.056  |  DISEASES
4860  |  PNP  |  1.723  |  DISEASES
100169750  |  PRINS  |  1.403  |  DISEASES
5788  |  PTPRC  |  3.373  |  DISEASES
399  |  RHOH  |  2.282  |  DISEASES
6016  |  RIT1  |  2.411  |  DISEASES
26168  |  SENP3  |  1.865  |  DISEASES
91137  |  SLC25A46  |  1.015  |  DISEASES
347734  |  SLC35B2  |  2.118  |  DISEASES
6664  |  SOX11  |  2.695  |  DISEASES
6693  |  SPN  |  1.237  |  DISEASES
8871  |  SYNJ2  |  2.275  |  DISEASES
8115  |  TCL1A  |  1.29  |  DISEASES
54790  |  TET2  |  1.385  |  DISEASES
7037  |  TFRC  |  1.411  |  DISEASES
7124  |  TNF  |  2.458  |  DISEASES
Locus
Symbol | Locus(Total Locus:1)
BRAF  |  7q34
Disease ID 528
Disease hairy cell leukemia
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:23)
HP:0100242  |  Sarcoma  |  3
HP:0001909  |  Leukemia  |  2
HP:0001945  |  Fever  |  2
HP:0001744  |  Splenomegaly  |  1
HP:0002716  |  Lymph node hyperplasia  |  1
HP:0012312  |  Low blood monocyte number  |  1
HP:0002090  |  Pneumonia  |  1
HP:0000573  |  Retinal hemorrhage  |  1
HP:0005506  |  Chronic myeloid leukemia  |  1
HP:0002665  |  Lymphoma  |  1
HP:0100806  |  Sepsis  |  1
HP:0001696  |  Situs inversus totalis  |  1
HP:0002633  |  Vasculitis  |  1
HP:0005550  |  Chronic lymphatic leukemia  |  1
HP:0001974  |  Leukocytosis  |  1
HP:0001875  |  Neutropenia  |  1
HP:0000988  |  Exanthem  |  1
HP:0000112  |  Nephropathy  |  1
HP:0002960  |  Autoimmune condition  |  1
HP:0001541  |  Ascites  |  1
HP:0012324  |  Myeloid leukemia  |  1
HP:0001876  |  Low blood cell count  |  1
HP:0002664  |  Neoplasia  |  1
Disease ID 528
Disease hairy cell leukemia
Manually Symptom
UMLS  | Name(Total Manually Symptoms:62)
C2707258  |  infections
C2364133  |  infection
C2355575  |  bone marrow fibrosis
C1963274  |  vasculitis
C1962974  |  chylothorax
C1704231  |  leukemic meningitis
C1556354  |  constitutional symptoms
C1555769  |  pulmonary disease
C1421374  |  porphyria cutanea tarda
C1373218  |  immunosuppression
C1318520  |  necrotising vasculitis
C1304413  |  paraneoplastic vasculitis
C1264047  |  abdominal lymphadenopathy
C1142578  |  bilateral pneumonia
C0854467  |  myelosuppression
C0796095  |  c syndrome
C0746883  |  neutropenic fever
C0694566  |  disseminated atypical mycobacterial infection
C0432408  |  trisomy 12
C0263325  |  transient acantholytic dermatosis
C0238051  |  cerebral vasculitis
C0206695  |  neuroendocrine carcinoma
C0162557  |  acute liver failure
C0162323  |  polyarthritis
C0151436  |  leukocytoclastic vasculitis
C0149678  |  epstein-barr virus infections
C0149678  |  epstein-barr virus infection
C0085077  |  sweet's syndrome
C0079744  |  diffuse large cell lymphoma
C0079731  |  b-cell lymphoma
C0042384  |  vasculitides
C0042384  |  angiitis
C0041326  |  pleural tuberculosis
C0040034  |  thrombocytopenia
C0038013  |  ankylosing spondylitis
C0037284  |  skin lesions
C0037140  |  b virus infection
C0036920  |  sezary syndrome
C0036572  |  seizures
C0036220  |  kaposi's sarcoma
C0036117  |  salmonella infection
C0031036  |  polyarteritis nodosa
C0030489  |  paraproteinemia
C0030312  |  pancytopenia
C0029464  |  osteosclerosis
C0027947  |  neutropenia
C0027627  |  secondary malignancies
C0026919  |  atypical mycobacterial infection
C0026916  |  mycobacterium avium-intracellulare infection
C0025289  |  meningitis
C0025202  |  malignant melanoma
C0024899  |  mast cell hyperplasia
C0023241  |  legionnaires' disease
C0023241  |  legionella pneumophila infection
C0023240  |  legionella infection
C0019829  |  hodgkin's disease
C0019655  |  histoplasmosis
C0018802  |  congestive cardiac failure
C0009324  |  ulcerative colitis
C0007114  |  skin cancers
C0002896  |  sideroblastic anemia
C0002880  |  autoimmune hemolytic anemia
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:5)
C0042384  |  vasculitis  |  1
C0009450  |  infection  |  1
C0032285  |  pneumonia  |  1
C0042384  |  vasculitides  |  1
C0030312  |  pancytopenia  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:32)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs11348802225700421673BRAFumls:C0023443BeFreeIn this issue of Blood, Pettirossi et al, including Drs Tiacci and Falini, who led the effort in 2011 defining the BRAF-V600E driving mutation in hairy cell leukemia (HCL),provide extensive laboratory studies showing that inhibitors of BRAF-V600E and/or mitogen-activated protein kinase kinase (MEK) reach their targets and cause HCL cell death0.1316722015BRAF7140753336AT,G,C
rs113488022261451733155HMGCLumls:C0023443BeFreeHMGCL expression is upregulated in BRAF V600E-expressing human primary melanoma and hairy cell leukemia cells.0.0002714422015BRAF7140753336AT,G,C
rs11348802224652320673BRAFumls:C0023443BeFreeAdvanced molecular techniques have identified distinct molecular aberrations in the Raf/MEK-ERK pathway and BRAF (V600E) mutations that drive the proliferation and survival of HCL B cells.0.1316722015BRAF7140753336AT,G,C
rs11348802222531170673BRAFumls:C0023443BeFreeApplication of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia.0.1316722012BRAF7140753336AT,G,C
rs11348802225511147673BRAFumls:C0023443BeFreeEvaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.0.1316722015BRAF7140753336AT,G,C
rs113488022246523205594MAPK1umls:C0023443BeFreeAdvanced molecular techniques have identified distinct molecular aberrations in the Raf/MEK-ERK pathway and BRAF (V600E) mutations that drive the proliferation and survival of HCL B cells.0.0010857672015BRAF7140753336AT,G,C
rs11348802222246856673BRAFumls:C0023443BeFreeReal-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia.0.1316722012BRAF7140753336AT,G,C
rs11348802222369373673BRAFumls:C0023443BeFreeThe high prevalence of BRAF(V600E) activating mutation in papillary thyroid carcinoma, cutaneous malignant melanoma and hairy cell leukemia implies that the mutation is an important 'driver' or 'codriver' in the development of a subset of these cancers.0.1316722012BRAF7140753336AT,G,C
rs11348802226145173673BRAFumls:C0023443BeFreeHMGCL expression is upregulated in BRAF V600E-expressing human primary melanoma and hairy cell leukemia cells.0.1316722015BRAF7140753336AT,G,C
rs11348802224689848673BRAFumls:C0023443BeFreeThey include the V600E BRAF mutation in hairy cell leukemia, the L265P MYD88 mutation in Waldenström macroglobulinemia, the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, and the Y640F//D661Y/V/H/I//N647I STAT3 mutations in T-cell large granular lymphocytic leukemia.0.1316722014BRAF7140753336AT,G,C
rs113488022246523202048EPHB2umls:C0023443BeFreeAdvanced molecular techniques have identified distinct molecular aberrations in the Raf/MEK-ERK pathway and BRAF (V600E) mutations that drive the proliferation and survival of HCL B cells.0.0010857672015BRAF7140753336AT,G,C
rs113488022250343645894RAF1umls:C0023443BeFreeRAF is among the most frequently mutated kinases, where BRAF V600E mutation occurs in most hairy cell leukemias (HCL) and half of malignant melanomas.0.0008143262014BRAF7140753336AT,G,C
rs1134880222503436422882ZHX2umls:C0023443BeFreeRAF is among the most frequently mutated kinases, where BRAF V600E mutation occurs in most hairy cell leukemias (HCL) and half of malignant melanomas.0.0008143262014BRAF7140753336AT,G,C
rs11348802223211289673BRAFumls:C0023443BeFreeWe conclude that the presence of pERK as detected by immunohistochemical staining is a useful surrogate marker for BRAF V600E in the diagnosis of HCL.0.1316722013BRAF7140753336AT,G,C
rs11348802225034364673BRAFumls:C0023443BeFreeWe investigated BRAF mutations in 36 subjects with different forms of SM, but could not detect BRAF mutation in any of the cases, not even in the mast cell lineage of a patient with V600E BRAF-positive HCL.0.1316722014BRAF7140753336AT,G,C
rs11348802222313586673BRAFumls:C0023443BeFreeCorrelation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype.0.1316722012BRAF7140753336AT,G,C
rs11348802226071465673BRAFumls:C0023443BeFreeImmunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.0.1316722015BRAF7140753336AT,G,C
rs11348802222072557673BRAFumls:C0023443BeFreeThe BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.0.1316722012BRAF7140753336AT,G,C
rs11348802224789721673BRAFumls:C0023443BeFreeDiscovery of the BRAF V600E mutation as a disease-defining genetic event in hairy cell leukemia can be helpful in both differential diagnosis and treatment of this disease.0.1316722014BRAF7140753336AT,G,C
rs11348802225511150673BRAFumls:C0023443BeFreeThe utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.0.1316722015BRAF7140753336AT,G,C
rs11348802223892906673BRAFumls:C0023443BeFreeThe thymidine kinase inhibitor vemurafenib, which inhibits the V600E mutant of BRAF, was reported to induce a CR in multiply relapsed and refractory HCL, with nearly complete clearing of MRD.0.1316722014BRAF7140753336AT,G,C
rs1134880222221087528395IGHV4-34umls:C0023443BeFreeBoth variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.0.0005428842012BRAF7140753336AT,G,C
rs11348802224994538673BRAFumls:C0023443BeFreeIn 2011, the V600E mutation of the BRAF gene in exon 15 was identified in HCL; being present in HCL, it is absent in the variant form of HCL (HCL-v) and in splenic red pulp lymphoma (SRPL), two entities related to HCL.0.1316722014BRAF7140753336AT,G,C
rs11348802222212971673BRAFumls:C0023443BeFreeRecently, the BRAF V600E mutation was uniformly identified in one HCL series, which may provide insights into the pathogenic mechanisms.0.1316722012BRAF7140753336AT,G,C
rs113488022246523205609MAP2K7umls:C0023443BeFreeAdvanced molecular techniques have identified distinct molecular aberrations in the Raf/MEK-ERK pathway and BRAF (V600E) mutations that drive the proliferation and survival of HCL B cells.0.0010857672015BRAF7140753336AT,G,C
rs11348802223349307673BRAFumls:C0023443BeFreeBesides confirming the constant presence of BRAF-V600E in all patients with hairy cell leukemia, we observed ubiquitous phospho-ERK expression in this malignancy.0.1316722013BRAF7140753336AT,G,C
rs11348802222210875673BRAFumls:C0023443BeFreeBoth variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.0.1316722012BRAF7140753336AT,G,C
rs11348802225120816673BRAFumls:C0023443BeFreeImmunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.0.1316722014BRAF7140753336AT,G,C
rs11348802222028477673BRAFumls:C0023443BeFreeBRAF-V600E was detected at different time points during the disease course, even after therapy, pointing to its pivotal role in HCL pathogenesis and maintenance of the leukemic clone.0.1316722012BRAF7140753336AT,G,C
rs11348802224433452673BRAFumls:C0023443BeFreeWe therefore suggest screening of BRAF V600E-negative HCL for alternative exon 11 mutations in the diagnostic setting.0.1316722013BRAF7140753336AT,G,C
rs37189676024689848673BRAFumls:C0023443BeFreeThey include the V600E BRAF mutation in hairy cell leukemia, the L265P MYD88 mutation in Waldenström macroglobulinemia, the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, and the Y640F//D661Y/V/H/I//N647I STAT3 mutations in T-cell large granular lymphocytic leukemia.0.1316722014ACAA1;MYD88338138714GT
rs38790727224689848673BRAFumls:C0023443BeFreeThey include the V600E BRAF mutation in hairy cell leukemia, the L265P MYD88 mutation in Waldenström macroglobulinemia, the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, and the Y640F//D661Y/V/H/I//N647I STAT3 mutations in T-cell large granular lymphocytic leukemia.0.1316722014MYD88338141150TC
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 528
Disease hairy cell leukemia
Case(Waiting for update.)